title: Intermolecular cross-talk between the prostaglandin E2 receptor (EP)3 of subtype and thromboxane A(2) receptor signalling in human erythroleukaemic cells.
abstract: OBJECTIVE
  In previous studies investigating cross-talk of signalling between prostaglandin (PG)E(2) receptor (EP) and the TPalpha and TPbeta isoforms of the human thromboxane (TX)A(2) receptor (TP), 17-phenyl trinor PGE(2)-induced desensitization of TP receptor signalling through activation of the AH6809 and SC19220-sensitive EP(1) subtype of the EP receptor family, in a cell-specific manner. Here, we sought to further investigate that cross-talk in human erythroleukaemic (HEL) 92.1.7 cells.
  
  
  METHODS
  Specificity of 17-phenyl trinor PGE(2) signalling and its possible cross-talk with signalling by TPalpha/TPbeta receptors endogenously expressed in HEL cells was examined through assessment of agonist-induced inositol 1,4,5-trisphosphate (IP)(3) generation and intracellular calcium ([Ca(2+)](i)) mobilization.
  
  
  RESULTS
  While 17-Phenyl trinor PGE(2) led to activation of phospholipase (PL)Cbeta to yield increases in IP(3) generation and [Ca(2+)](i), it did not desensitize but rather augmented that signalling in response to subsequent stimulation with the TXA(2) mimetic U46619. Furthermore, the augmentation was reciprocal. Signalling by 17-phenyl trinor PGE(2) was found to occur through AH6809- and SC19920-insensitive, Pertussis toxin-sensitive, G(i)/G(betagamma)-dependent activation of PLCbeta. Further pharmacological investigation using selective EP receptor subtype agonists and antagonists confirmed that 17-phenyl trinor PGE(2)-mediated signalling and reciprocal cross-talk with the TP receptors occurred through the EP(3), rather than the EP(1), EP(2) or EP(4) receptor subtype in HEL cells.
  
  
  CONCLUSIONS
  The EP(1) and EP(3) subtypes of the EP receptor family mediated intermolecular cross-talk to differentially regulate TP receptor-mediated signalling whereby activation of EP(1) receptors impaired or desensitized, while that of EP(3) receptors augmented signalling through TPalpha/TPbeta receptors, in a cell type-specific manner.
authors.affiliation: Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Ireland.
authors.forename: Helen M
authors.initials: HM
authors.lastname: Reid
authors.forename: B Therese
authors.initials: BT
authors.lastname: Kinsella
mesh_terms: D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002460:Cell Line; D045744:Cell Line, Tumor; D015232:Dinoprostone / Q000031:analogs & derivatives / Q000494:pharmacology; D004789:Enzyme Activation; D044385:GTP-Binding Protein alpha Subunits / Q000502:physiology; D006801:Humans; D015544:Inositol 1,4,5-Trisphosphate / Q000096:biosynthesis; D054799:Phospholipase C beta / Q000378:metabolism; D020033:Protein Isoforms / Q000096:biosynthesis; D020239:Receptor Cross-Talk; D018078:Receptors, Prostaglandin E / Q000819:agonists / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology*; D058306:Receptors, Prostaglandin E, EP1 Subtype; D058308:Receptors, Prostaglandin E, EP3 Subtype; D044244:Receptors, Thromboxane A2, Prostaglandin H2 / Q000502:physiology*; D015398:Signal Transduction
chemical_list: C092396:17-phenyltrinorprostaglandin E2; D044385:GTP-Binding Protein alpha Subunits; C545635:PTGER1 protein, human; C545647:PTGER3 protein, human; D020033:Protein Isoforms; D018078:Receptors, Prostaglandin E; D058306:Receptors, Prostaglandin E, EP1 Subtype; D058308:Receptors, Prostaglandin E, EP3 Subtype; D044244:Receptors, Thromboxane A2, Prostaglandin H2; C016767:sulprostone; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D015544:Inositol 1,4,5-Trisphosphate; D054799:Phospholipase C beta; D015232:Dinoprostone; D002118:Calcium
references.citation: Biochem Pharmacol. 2001 Jul 15;62(2):229-39
references.pmid: 11389883
references.citation: Blood. 1983 Oct;62(4):832-45
references.pmid: 6309287
references.citation: Br J Pharmacol. 2006 Nov;149(6):611-23
references.pmid: 17016496
references.citation: J Biol Chem. 2002 Nov 29;277(48):46035-42
references.pmid: 12297509
references.citation: Biochim Biophys Acta. 1995 Feb 16;1265(1):8-14
references.pmid: 7532011
references.citation: Biochim Biophys Acta. 1998 Nov 27;1425(3):543-59
references.pmid: 9838218
references.citation: J Clin Invest. 1990 Apr;85(4):1072-84
references.pmid: 2318965
references.citation: FEBS J. 2005 Feb;272(4):1036-53
references.pmid: 15691336
references.citation: Arterioscler Thromb Vasc Biol. 1997 Sep;17(9):1830-6
references.pmid: 9327784
references.citation: Biochim Biophys Acta. 2007 Jun;1773(6):970-89
references.pmid: 17466390
references.citation: Biochim Biophys Acta. 2006 Sep;1761(9):1114-31
references.pmid: 16956790
references.citation: J Pharmacol Exp Ther. 1997 May;281(2):957-64
references.pmid: 9152406
references.citation: Cardiovasc Res. 2006 Jun 1;70(3):446-56
references.pmid: 16458868
references.citation: J Lipid Res. 2008 Dec;49(12):2590-604
references.pmid: 18698092
references.citation: Annu Rev Physiol. 1999;61:169-92
references.pmid: 10099686
references.citation: ScientificWorldJournal. 2007 Sep 01;7:1359-74
references.pmid: 17767355
references.citation: Biochemistry. 1992 Apr 7;31(13):3370-7
references.pmid: 1313295
references.citation: Blood. 1997 Aug 1;90(3):1039-46
references.pmid: 9242534
references.citation: Br J Pharmacol. 2004 May;142(1):203-21
references.pmid: 15100160
references.citation: Circulation. 2001 Sep 4;104(10):1176-80
references.pmid: 11535576
references.citation: Pharmacol Rev. 1994 Jun;46(2):205-29
references.pmid: 7938166
references.citation: Annu Rev Pharmacol Toxicol. 2001;41:661-90
references.pmid: 11264472
references.citation: J Pharmacol Exp Ther. 1991 Aug;258(2):607-12
references.pmid: 1650837
references.citation: J Biomol Screen. 2004 Jun;9(4):343-53
references.pmid: 15191651
references.citation: Biochem J. 1983 May 15;212(2):473-82
references.pmid: 6309146
references.citation: J Biol Chem. 1993 Dec 15;268(35):26767-72
references.pmid: 8253813
references.citation: Biochim Biophys Acta. 2000 Apr 17;1496(2-3):164-82
references.pmid: 10771086
references.citation: Biochemistry. 1994 Dec 6;33(48):14496-502
references.pmid: 7981210
references.citation: J Biol Chem. 1999 Apr 30;274(18):12774-9
references.pmid: 10212262
references.citation: J Biol Chem. 2003 Dec 19;278(51):51190-202
references.pmid: 14530262
references.citation: Genomics. 1997 Mar 15;40(3):425-34
references.pmid: 9073510
references.citation: Eur J Biochem. 2002 Aug;269(16):4058-73
references.pmid: 12180983
references.citation: J Biol Chem. 2000 Jul 7;275(27):20412-23
references.pmid: 10827090
references.citation: Biochem Pharmacol. 2006 Apr 28;71(9):1308-23
references.pmid: 16499875
references.citation: J Biol Chem. 2007 Apr 20;282(16):11613-7
references.pmid: 17329241
references.citation: J Biol Chem. 2003 Aug 15;278(33):30725-31
references.pmid: 12796499
references.citation: J Clin Endocrinol Metab. 2000 Nov;85(11):4315-22
references.pmid: 11095474
references.citation: J Biol Chem. 1985 Mar 25;260(6):3440-50
references.pmid: 3838314
references.citation: Eur J Pharmacol. 1997 Nov 12;338(3):277-87
references.pmid: 9424022
references.citation: J Biol Chem. 1991 Aug 25;266(24):15771-81
references.pmid: 1874734
references.citation: J Biol Chem. 1995 Mar 24;270(12):7011
references.pmid: 7896853
references.citation: J Clin Invest. 1996 Feb 15;97(4):949-56
references.pmid: 8613548
references.citation: Int J Biochem Cell Biol. 2004 Jul;36(7):1187-205
references.pmid: 15109566
references.citation: J Biol Chem. 1998 Jul 24;273(30):18677-80
references.pmid: 9668034
references.citation: FEBS J. 2005 Sep;272(18):4754-73
references.pmid: 16156795
references.citation: FEBS Lett. 2004 Aug 13;572(1-3):271-5
references.pmid: 15304361
references.citation: J Biol Chem. 1994 Jul 29;269(30):19256-61
references.pmid: 8034687
references.citation: Mol Pharmacol. 1995 Nov;48(5):869-79
references.pmid: 7476918
references.citation: J Biol Chem. 1997 Apr 11;272(15):10151-9
references.pmid: 9092561
references.citation: FEBS Lett. 1992 Sep 14;309(3):381-4
references.pmid: 1516714
references.citation: Prostaglandins Other Lipid Mediat. 2004 Oct;74(1-4):101-12
references.pmid: 15560119
references.citation: Nature. 1991 Feb 14;349(6310):617-20
references.pmid: 1825698
references.citation: Cell. 1997 Apr 4;89(1):105-14
references.pmid: 9094719
references.citation: J Biol Chem. 2002 Jul 26;277(30):27053-64
references.pmid: 12016224
references.citation: J Biol Chem. 1997 Mar 14;272(11):7191-200
references.pmid: 9054415
references.citation: Blood. 2004 Sep 15;104(6):1745-52
references.pmid: 15187029
references.citation: Thromb Haemost. 1998 May;79(5):1014-20
references.pmid: 9609239
references.citation: J Clin Invest. 2001 Jul;108(1):25-30
references.pmid: 11435452
references.citation: J Biol Chem. 1999 Jan 29;274(5):2645-51
references.pmid: 9915793
references.citation: Biochem Biophys Res Commun. 1994 Feb 15;198(3):999-1006
references.pmid: 8117308
references.citation: Physiol Rev. 1999 Oct;79(4):1193-226
references.pmid: 10508233
references.citation: Annu Rev Physiol. 2001;63:579-605
references.pmid: 11181968
references.citation: Exp Mol Med. 2004 Jun 30;36(3):220-5
references.pmid: 15272233
references.citation: ScientificWorldJournal. 2007 Sep 01;7:1329-47
references.pmid: 17767353
references.citation: Biochem Biophys Res Commun. 2000 Nov 11;278(1):224-8
references.pmid: 11071876
references.citation: J Biol Chem. 2004 Dec 17;279(51):53036-47
references.pmid: 15471868
references.citation: Br J Pharmacol. 2008 Mar;153 Suppl 2:S1-209
references.pmid: 18347570
references.citation: J Pharmacol Exp Ther. 2004 Jun;309(3):1213-20
references.pmid: 14872092
references.citation: Mol Pharmacol. 2002 Apr;61(4):817-31
references.pmid: 11901221
references.citation: Biochem Soc Trans. 2001 Nov;29(Pt 6):641-54
references.pmid: 11709048
references.citation: Eur J Biochem. 1995 Feb 15;228(1):23-30
references.pmid: 7883006
references.citation: Neuro Oncol. 2008 Oct;10(5):661-74
references.pmid: 18715952
references.citation: Science. 1982 Jun 11;216(4551):1233-5
references.pmid: 6177045
references.citation: Eur J Pharmacol. 2005 Apr 11;512(2-3):223-30
references.pmid: 15840408
references.citation: Br J Pharmacol. 2000 Oct;131(3):601-9
references.pmid: 11015313